Osaic Holdings’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Buy |
52,191
+2,645
| +5% | +$27.8K | ﹤0.01% | 2733 |
|
|
2025
Q1 | $388K | Sell |
49,546
-2,825
| -5% | -$22.1K | ﹤0.01% | 3090 |
|
|
2024
Q4 | $550K | Buy |
52,371
+34,819
| +198% | +$366K | ﹤0.01% | 2707 |
|
|
2024
Q3 | $230K | Buy |
17,552
+15,520
| +764% | +$204K | ﹤0.01% | 3535 |
|
|
2024
Q2 | $28.6K | Sell |
2,032
-3,226
| -61% | -$45.4K | ﹤0.01% | 5054 |
|
|
2024
Q1 | $88.8K | Sell |
5,258
-1,161
| -18% | -$19.6K | ﹤0.01% | 4323 |
|
|
2023
Q4 | $90.6K | Sell |
6,419
-14,178
| -69% | -$200K | ﹤0.01% | 4499 |
|
|
2023
Q3 | $212K | Buy |
20,597
+957
| +5% | +$9.86K | ﹤0.01% | 3950 |
|
|
2023
Q2 | $324K | Buy |
19,640
+2,439
| +14% | +$40.2K | ﹤0.01% | 3519 |
|
|
2023
Q1 | $158K | Sell |
17,201
-600
| -3% | -$5.5K | ﹤0.01% | 4060 |
|
|
2022
Q4 | $128K | Buy |
17,801
+1,700
| +11% | +$12.2K | ﹤0.01% | 4249 |
|
|
2022
Q3 | $81K | Buy |
16,101
+13,975
| +657% | +$70.3K | ﹤0.01% | 4536 |
|
|
2022
Q2 | $5K | Hold |
2,126
| – | – | ﹤0.01% | 6411 |
|
|
2022
Q1 | $15K | Sell |
2,126
-63
| -3% | -$444 | ﹤0.01% | 5840 |
|
|
2021
Q4 | $18K | Buy |
2,189
+23
| +1% | +$189 | ﹤0.01% | 5821 |
|
|
2021
Q3 | $21K | Sell |
2,166
-8,047
| -79% | -$78K | ﹤0.01% | 5710 |
|
|
2021
Q2 | $69K | Sell |
10,213
-1,000
| -9% | -$6.76K | ﹤0.01% | 4787 |
|
|
2021
Q1 | $101K | Hold |
11,213
| – | – | ﹤0.01% | 4325 |
|
|
2020
Q4 | $75K | Sell |
11,213
-4,738
| -30% | -$31.7K | ﹤0.01% | 4245 |
|
|
2020
Q3 | $80K | Buy |
15,951
+9,951
| +166% | +$49.9K | ﹤0.01% | 3981 |
|
|
2020
Q2 | $48K | Buy |
6,000
+5,300
| +757% | +$42.4K | ﹤0.01% | 4196 |
|
|
2020
Q1 | $6K | Buy |
+700
| New | +$6K | ﹤0.01% | 5192 |
|